Literature DB >> 1864264

Benzene-induced micronuclei formation in mouse fetal liver blood, peripheral blood, and maternal bone marrow cells.

H Ning1, N Y Kado, P A Kuzmicky, D P Hsieh.   

Abstract

The transplacental cytogenetic effects of benzene were studied by using the micronucleus test of polychromatic erythrocytes (PCE) found in both fetal liver and fetal peripheral blood, and were compared with PCE from maternal bone marrow. Timed-pregnant mice received single intraperitoneal doses of benzene (0, 109, 219, 437, or 874 mg/kg bw) on the 14th day of gestation and were sacrificed 21 hr after injection. Benzene elicited a significant increase (P less than 0.01) in the frequency of micronucleated polychromatic erythrocytes (MNPCE) in fetal liver blood cells (0.55 to 1.36%, control 0.18%) at doses of 219 to 874 mg/kg, and in fetal peripheral blood cells (0.49 to 0.58%, control 0.25%) and maternal bone marrow cells (0.53 to 0.70%, control 0.10%) at doses of 437 and 874 mg/kg. The data demonstrate that benzene is a moderate transplacental clastogenic agent, and that the mouse transplacental micronucleus test using fetal liver blood cells is a potentially more sensitive indicator of the genotoxicity of benzene than either fetal peripheral blood or maternal bone marrow cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864264     DOI: 10.1002/em.2850180102

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  2 in total

1.  Parental, In Utero, and Early-Life Exposure to Benzene and the Risk of Childhood Leukemia: A Meta-Analysis.

Authors:  Frolayne M Carlos-Wallace; Luoping Zhang; Martyn T Smith; Gabriella Rader; Craig Steinmaus
Journal:  Am J Epidemiol       Date:  2015-11-20       Impact factor: 4.897

2.  Paternal Smoking Before Conception and During Pregnancy Is Associated With an Increased Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis of 17 Case-Control Studies.

Authors:  Yue Cao; Jing Lu; Jing Lu
Journal:  J Pediatr Hematol Oncol       Date:  2020-01       Impact factor: 1.170

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.